| CIM11 |
5A13.1 |
Diabetes mellitus due to genetic defects in insulin action
|
|
| CIM11 |
5A13.2 |
Diabetes mellitus due to diseases of the exocrine pancreas
|
|
| CIM11 |
5A13.3 |
Diabetes mellitus due to endocrinopathies
|
|
| CIM11 |
5A13.4 |
Diabetes mellitus due to drug or chemical
|
|
| CIM11 |
5A13.5 |
Diabetes mellitus due to uncommon forms of immune-mediated diabetes
|
|
| CIM11 |
5A13.6 |
Diabetes mellitus due to other genetic syndromes
|
|
| CIM11 |
5A13.7 |
Diabetes mellitus due to clinically defined subtypes or syndromes
|
|
| CIM11 |
5A14 |
Diabetes mellitus, type unspecified
|
|
| CIM11 |
5A20 |
Diabetic hyperosmolar hyperglycaemic state
|
|
| CIM11 |
5A20.0 |
Hyperosmolar hyperglycaemic state without coma
|
|
| CIM11 |
5A20.1 |
Hyperosmolar hyperglycaemic state with coma
|
|
| CIM11 |
5A21 |
Hypoglycaemia in the context of diabetes mellitus
|
|
| CIM11 |
5A21.0 |
Hypoglycaemia in the context of diabetes mellitus without coma
|
|
| CIM11 |
5A21.1 |
Hypoglycaemia in the context of diabetes mellitus with coma
|
|
| CIM11 |
5A22 |
Diabetic acidosis
|
|
| CIM11 |
5A22.0 |
Diabetic ketoacidosis without coma
|
|
| CIM11 |
5A22.1 |
Diabetic lactic acidosis
|
|
| CIM11 |
5A22.2 |
Diabetic metabolic acidosis
|
|
| CIM11 |
5A22.3 |
Diabetic ketoacidosis with coma
|
|
| CIM11 |
5A23 |
Diabetic coma
|
|
| CIM11 |
5A24 |
Uncontrolled or unstable diabetes mellitus
|
|
| CIM11 |
5A40 |
Intermediate hyperglycaemia
|
|
| CIM11 |
5A40.0 |
Impaired fasting glucose
|
|
| CIM11 |
5A40.1 |
Impaired glucose tolerance
|
|
| CIM11 |
5A41 |
Hypoglycaemia without associated diabetes
|
|
| CIM11 |
5A42 |
Increased secretion of glucagon
|
|
| CIM11 |
5A43 |
Abnormal secretion of gastrin
|
|
| CIM11 |
5A43.0 |
Drug-induced hypergastrinaemia
|
|
| CIM11 |
5A43.1 |
Zollinger-Ellison syndrome
|
|
| CIM11 |
5A44 |
Insulin-resistance syndromes
|
|
| CIM11 |
5A45 |
Persistent hyperinsulinaemic hypoglycaemia of infancy
|
|
| CIM11 |
5A50 |
Hypoparathyroidism
|
|
| CIM11 |
5A50.0 |
Hypoparathyroidism due to impaired parathyroid hormone secretion
|
|
| CIM11 |
5A50.00 |
Idiopathic hypoparathyroidism
|
|
| CIM11 |
5A50.01 |
Secondary hypoparathyroidism
|
|
| CIM11 |
5A50.02 |
Hypoparathyroidism due to destruction of the parathyroid glands
|
|
| CIM11 |
5A50.03 |
Autoimmune hypoparathyroidism
|
|
| CIM11 |
5A50.1 |
Pseudohypoparathyroidism
|
|
| CIM11 |
5A51 |
Hyperparathyroidism
|
|
| CIM11 |
5A51.0 |
Primary hyperparathyroidism
|
|
| CIM11 |
5A51.1 |
Secondary hyperparathyroidism
|
|
| CIM11 |
5A51.2 |
Familial hypocalciuric hypercalcaemia
|
|
| CIM11 |
5A60 |
Hyperfunction of pituitary gland
|
|
| CIM11 |
5A60.0 |
Acromegaly or pituitary gigantism
|
|
| CIM11 |
5A60.1 |
Hyperprolactinaemia
|
|
| CIM11 |
5A60.2 |
Syndrome of inappropriate secretion of antidiuretic hormone
|
|
| CIM11 |
5A60.20 |
Nephrogenic syndrome of inappropriate antidiuresis
|
|
| CIM11 |
5A60.3 |
Central precocious puberty
|
|
| CIM11 |
5A61 |
Hypofunction or certain other specified disorders of pituitary gland
|
|
| CIM11 |
5A61.0 |
Hypopituitarism
|
|